Our latest press releases, media appearances and news commentary.
The Catapult Network is ready to play a key role in implementing the strategy and supporting industrial sectors to innovate.
The CEOs of all nine Catapults came together at a special event held in the High Value Manufacturing Catapult’s MTC in Coventry to sign the shared Inclusivity in Innovation Charter.
Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as you go, AI platform for drug discovery.
Medicines Discovery Catapult (MDC) is proud to announce an extension to its talented workforce.
The Alderley Park facility received the award for its integral role in establishing the Lighthouse Laboratory network.
The UK’s centre for therapeutics innovation, Medicines Discovery Catapult (MDC), has received a £5 million grant to build a Translational Research Facility in Infectious Disease on its Alderley Park site.
Chris Molloy, Chief Executive Officer of the Medicines Discovery Catapult will be stepping down in September 2021 after five years in the role.
Psychiatric drug discovery must be a truly collaborative process if it is to be successful.
While student perceptions of careers in science may come with a lack of diversity, the Covid-19 pandemic has highlighted the important contributions made by scientists and healthcare professionals…
See how we can help support you with your next drug discovery project.
Speak to us
